Volker Schroeckh

Title: Volker Schroeckh: Innovator in Targeted Chemotherapy

Introduction

Volker Schroeckh is a notable inventor based in Rothenstein, Germany. He has made significant contributions to the field of targeted chemotherapy through his innovative research and development. His work focuses on molecular probes that enhance the effectiveness of chemotherapeutics in treating bacterial infections.

Latest Patents

Volker Schroeckh holds a patent for "Molecular probes for targeting of cell density-indicating compounds." This invention presents a novel approach for targeting chemotherapeutics to focal bacterial infections characterized by high densities of various bacteria. The patent outlines how extracellular signal molecules, which indicate cell density, can be utilized to improve the targeting of photosensitizers in photodynamic antimicrobial chemotherapy (PACT). The invention emphasizes the use of molecular modules that combine targeting and chemotherapeutical components, allowing for more effective treatment of infections caused by both gram-negative and gram-positive bacteria.

Career Highlights

Throughout his career, Schroeckh has been associated with Biolitec AG, a company dedicated to advancing medical technologies. His work has led to the development of innovative solutions that address critical challenges in the medical field, particularly in the treatment of bacterial infections.

Collaborations

Volker Schroeckh has collaborated with notable colleagues, including Dieter Riesenberg and Burkhard Gitter. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Volker Schroeckh's contributions to targeted chemotherapy through his patented innovations demonstrate his commitment to improving medical treatments for bacterial infections. His work continues to influence the field and offers promising solutions for future medical challenges.